Where nutrition investors are based
The United States carries most of the nutrition list in AngelMatch, and it isn't close. California and New York alone account for well over a quarter of every nutrition investor in the database, with San Francisco and New York City doing most of that heavy lifting. Outside the US, the biggest concentrations sit in the United Kingdom, the Netherlands, Canada, and France, which lines up with where the functional food, personalized nutrition, and alt-protein scenes have actually built momentum over the past few years.
That geography matters for how you spend your outreach time. A founder building a US direct-to-consumer supplement brand and a founder building European personalized-nutrition software are pitching almost entirely different investor pools, even though both would show up under the same "nutrition" tag. Before you build a list, it's worth checking whether your closest comparable companies raised from local funds or from investors who cover the whole category regardless of geography. You can browse the full investor database by location if you want to see who's active near you specifically, rather than guessing from a national average.
The Netherlands and France both punch above their size on this list, which tracks with how much of Europe's alt-protein and precision fermentation activity has clustered there. If you're raising outside the US, it's worth checking whether the investors you're targeting actually write checks into your country, since a fund's stated focus doesn't always match where it puts real capital. A quick look at a fund's last two or three deals tells you more than its "about" page does.
If you're US-based, it's still worth scanning the full United States investors list rather than stopping at the nutrition tag alone, especially if your company also touches wellness, digital health, or general consumer software. A lot of generalist investors who don't tag themselves under nutrition specifically still write checks into the category when the business model looks familiar to them.
What stage and check size nutrition investors write at
Most of the nutrition list sits at seed and early stage venture, with a smaller pre-seed and Series A pool behind them. That's a fairly typical shape for a consumer-adjacent category: a lot of investors are comfortable writing a first check into a nutrition brand or platform, fewer stick around once a company needs to prove out manufacturing, distribution, or clinical claims at scale.
Check sizes follow the usual pattern across the site. Angel investors in nutrition generally write checks between $25,000 and $500,000, and venture checks run from $2 million up to $100 million or more once a company is further along. Founders raising a first round should expect dilution of roughly 15% to 25% at that stage, which is worth having in your head before you start negotiating a term sheet. If you're specifically hunting for early believers rather than growth-stage capital, the venture capitalists and angel investors on the list skew heavily toward that seed and early stage range, not the later, bigger checks.
The small pool at Series B and beyond isn't a sign that nutrition companies can't scale. It's a sign that fewer nutrition-focused funds carry checkbooks big enough for a growth round, so companies at that stage often end up raising from generalist healthcare or consumer funds instead of specialists. If you're approaching a Series B, don't limit yourself to investors who describe themselves as "nutrition" investors first. Look at who has actually funded a nutrition, wellness, or food company at your stage in the last year or two, regardless of how they label their own focus.
What's driving nutrition investment right now
The broader foodtech category nutrition sits inside has been on a real run. Funding into foodtech startups grew nearly tenfold over the past five years and reached $10.8 billion in 2025, with early 2026 data pointing to another year of growth rather than a pullback. Nutrition specifically doesn't get its own separate tracker most places, but it rides that same wave, especially in personalized nutrition, functional food and beverage, and nutrition-adjacent healthcare.
You can see that pattern in individual rounds too. Nourish, a New York-based platform that connects patients with insurance-covered dietitians, has now raised over $200 million in total equity funding, a sign that investors will back nutrition when it's wrapped in a business model that looks more like healthcare than like a supplement brand. If your own pitch leans that direction, that comparison is worth naming directly rather than leaving investors to guess at it. Investors interested in that intersection often overlap with the digital health list as much as the nutrition one, so it's worth checking both.
The category has also gotten more selective, not less active. Investors who write nutrition checks in 2026 want to see a real path to margin, not just a compelling mission. A supplement or functional food brand with strong repeat purchase rates and clean unit economics is a much easier sell right now than one leaning on total addressable market slides alone. If you're a software or platform play rather than a physical product company, the bar is similar: show usage that sticks, not just signups.
One trend worth knowing about if you haven't fundraised in this category before: large food and ingredients companies have gotten more active as strategic investors. DSM Ventures, the corporate venture arm of the ingredients company DSM-Firmenich, invests directly in nutrition, health, and animal nutrition startups alongside its own business units, and it's not the only ingredients or CPG company running a venture arm this way. A strategic check from an investor like that can come with distribution and formulation partnerships a pure financial investor can't offer, but it can also come with more strings attached, so it's worth asking early what rights or exclusivity a strategic is expecting before you take the meeting too far.
How to approach nutrition investors
Nutrition pitches get judged on evidence more than most consumer categories, so lead with it. If you have clinical data, a registered dietitian on staff, or even early outcome data from users, put that in the first two lines of your outreach, not buried in an appendix. Investors in this space have seen enough supplement brands built on marketing alone that credible science is genuinely a differentiator, not just a nice-to-have.
Regulatory and label claims matter more here than in most software pitches, and it's worth showing investors you understand that early. A founder who can speak plainly about what they can and can't claim on packaging, and how that shapes the product roadmap, reads as someone who has actually operated in the category, not just researched it. That's a small thing that separates a serious pitch from a generic one.
Timing helps too. Consumer nutrition interest spikes hard in January, and a lot of investor attention follows it, so if you're launching a consumer nutrition brand, raising in the fourth quarter ahead of that wave tends to land better than raising in the quiet summer months. B2B and platform nutrition companies don't see the same seasonality, so that timing advice applies mainly if you're selling directly to consumers. Keep a simple log of who you've talked to and when you last followed up. A basic fundraising CRM is enough to stop good conversations from going cold while you're heads-down on the product.
Nutrition is a big enough category on AngelMatch that filtering matters. Cross-reference the nutrition list against stage, location, and investor type before you send a single email, since a venture capitalist writing $5 million Series A checks and an angel writing a first $25,000 check need completely different pitches, even if they're both tagged to the same market. Investors who split their time between nutrition and food and beverage often see more deal flow than pure nutrition specialists, so it's worth reading their recent deals before assuming they're a fit. Once you've narrowed the list down, a clean, current pitch deck link makes it easy for the right investors to say yes fast, which matters most once you've already done the work to find the ones who are actually a match for your stage and geography.
Wellness investors
